Question special

In clinical practice, we typically target a goal MAP of >65 mmHg.
In the study design, the primary endpoint was MAP >75 mm Hg or increase of at least 10 mm Hg from baseline. I see that the definition of vasodilatory shock included MAP between 55-70 mmHg and that randomization was stratified according to MAP <65 or >65 and I imagine that these are related to the goal blood pressure selected for the primary outcome.